Diabetes decisions — 2022
3,546 indexed Board decisions in 2022.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: DeniedDecember 2022
The Board denied service connection for loss of use of the right hand, left hand, right foot, and left foot as secondary to diabetic peripheral neuropathy.,The Veteran's claim was not granted because there is no separate diagnosis of a hand or foot disorder distinct from his already service-connected diabetes mellitus.
- Whole decision: GrantedDecember 2022
The Veteran's bladder cancer was rated at 100% from October 15, 2018 through September 30, 2020. Additionally, the Veteran's service-connected diabetes and diabetic neuropathy were combined to result in a 70% rating during this period, meeting the criteria for Special Monthly Compensation (SMC) at the 's' rate.
- Whole decision: GrantedPACT Act · December 2022
The Veteran's diabetes mellitus type II is granted as presumptively related to his exposure to herbicide agents during active service in Thailand, based on the PACT Act.
- Whole decision: GrantedPACT Act · December 2022
The Veteran's service connection for diabetes mellitus type 2 is granted due to presumed exposure to herbicide agents under the PACT Act.
- Whole decision: GrantedDecember 2022
The Veteran's combined service-connected disabilities render him unable to secure or follow a substantially gainful occupation since October 31, 2014. His TDIU claim is granted.
- Whole decision: Remanded (sent back)December 2022
The Board has remanded the claims for diabetes mellitus, prostate cancer, and erectile dysfunction due to insufficient evidence or need for further examination.
- Whole decision: Remanded (sent back)December 2022
The Board has found that a remand is necessary to obtain a VA occupational evaluation due to the Veteran's service-connected disabilities, which may affect his ability to secure and follow substantially gainful employment.
- Whole decision: Remanded (sent back)December 2022
The Veteran's increased ratings claims for diabetic retinopathy and neuropathy were denied, and the Board finds that a VA examination was needed to evaluate his diabetes. The case is being remanded to provide these examinations.
- Whole decision: GrantedDecember 2022
The Veteran's diabetes mellitus is found to be causally related to an in-service event, specifically his service from January 1960 to April 1969. As a result, the claim for service connection for diabetes mellitus is granted.
- Whole decision: Remanded (sent back)December 2022
The Board has remanded the case due to inadequate opinions regarding the onset and etiology of the Veteran's diabetes mellitus. The Veteran contends that his diabetes mellitus began during service, but the VA examiner did not adequately address this claim.
- Whole decision: Remanded (sent back)December 2022
The Board has determined that additional development is necessary to address the Veteran's claims for service connection, including determining if he was exposed to herbicide agents during his military service and whether his current conditions are related to such exposure.
- Whole decision: Remanded (sent back)PACT Act · December 2022
The Veteran's diabetes mellitus and hypertension are presumed to be related to service due to exposure to herbicide agents. However, the direct service connection for diabetes mellitus and hypertension is remanded as there is insufficient evidence regarding their cause.
- Whole decision: Remanded (sent back)December 2022
The Board has determined that the VA examinations and medical opinions provided were not sufficient to adjudicate the Veteran's claims for service connection. These matters are being remanded for further development.
- Whole decision: GrantedDecember 2022
The Veteran's service-connected PTSD, left and right upper extremity peripheral neuropathy, and diabetic peripheral neuropathy in the lower limbs have been granted from April 28, 2017. The Veteran is now rated at 30% for PTSD.
- Whole decision: DeniedDecember 2022
The Board denied service connection for type II diabetes mellitus and its residuals, including diabetic neuropathy of the bilateral upper and lower extremities. The evidence did not support a finding that these conditions were related to service or service-connected disabilities.
- Whole decision: Remanded (sent back)December 2022
The Board has granted service connection for diabetes mellitus due to herbicide exposure, but has remanded the issue of service connection for an eye disability (macular degeneration) as due to herbicide exposure.
- Whole decision: GrantedDecember 2022
The Veteran's service-connected disabilities, including PTSD, coronary artery disease, diabetes mellitus, and peripheral neuropathy of the lower extremities, render him unable to secure or maintain gainful employment.
- Whole decision: DismissedDecember 2022
The Board has dismissed the appeals regarding service connection for back disability, diabetes mellitus type II, right lower extremity peripheral neuropathy, and left lower extremity peripheral neuropathy due to the Veteran's withdrawal of his appeal.
- Whole decision: DeniedDecember 2022
The Board has denied service connection for diabetes mellitus and diabetic neuropathy of the bilateral upper and lower extremities, finding that there is not an approximate balance of positive and negative evidence.
- Whole decision: DismissedDecember 2022
The Board has dismissed the appeals for diabetes mellitus type II, hypertension, and a cardiac condition. The appeal for residuals of traumatic brain injury is denied. The appeal for ulcers is remanded.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.